natgillin/translations-raw huggingface dataset:
Contact your nearest hospital Accident and Emergency department or a doctor for advice if you have swallowed more capsules than you have been told to take or if you think a child has swallowed any.
Ako popijete više kapsula nego što Vam je propisano ili ako mislite da je Vaše dijete progutalo kapsulu, za savjet se obratite na odjel hitne službe u najbližoj bolnici ili svom liječniku.
• infection of the digestive tract
• infekcija probavnog sustava
Cases of pure red cell aplasia (PRCA) have been reported in patients treated with mycophenolate mofetil in combination with other immunosuppressants.
Pure Red Cell Aplasia, PRCA) kod bolesnika liječenih mofetilmikofenolatom u kombinaciji s drugim imunosupresivima.
Spontaneous abortion (rate of 45% to 49%) and congenital malformations (estimated rate of 23% to 27%) have been reported following MMF exposure during pregnancy.
Nakon izlaganja mofetilmikofenolatu tijekom trudnoće prijavljeni su spontani pobačaj (stopa od 45% do 49%) i kongenitalne malformacije
Medicinal products that interfere with enterohepatic circulation (e.g. cholestyramine, ciclosporin A, antibiotics)
Lijekovi koji utječu na glukuronidaciju (npr. izavukonazol, telmisartan)
Indigo carmine (E132)
Kapica indigo karmin (E132) titanijev dioksid (E171) želatina
Patients receiving Myfenax should be instructed to report immediately any evidence of infection, unexpected bruising, bleeding or any other manifestation of bone marrow depression.
Bolesnike koji primaju Myfenax potrebno je uputiti da odmah prijave bilo koji znak infekcije,
Povidone K-30
IgG-a na normalu.
The systemic exposure at this dose represents 2-3°times the clinical exposure at the recommended clinical dose of 2 g/day in renal transplant patients and 1.3-2°times the clinical exposure at the recommended clinical dose of 3 g/day in cardiac transplant patients.
Sistemska izloženost pri tim dozama je 2 - 3 puta veća od kliničke izloženosti pri preporučenoj kliničkoj dozi od 2 g/dan kod bolesnika s presađenim bubregom i 1,3 - 2 puta veće od kliničke izloženosti pri preporučenoj kliničkoj dozi od 3 g/dan kod bolesnika s presađenim srcem.
Body: caramel opaque, printed ‘250' axially in black ink.
Tijelo: neprozirno, boje karamela s oznakom ‘250' uzdužno utisnutom crnom tintom Kapica: neprozirna, svijetlo plava s oznakom ‘M' uzdužno utisnutom crnom tintom.
Mycophenolate mofetil had no effect on fertility of male rats at oral doses up to 20 mg/kg/day.
Pri oralnim dozama do 20 mg/kg/dan, mofetilmikofenolat nije utjecao na plodnost muških štakora.
Myfenax 250mg hard capsules Mycophenolate mofetil
Myfenax 250 mg tvrde kapsule mofetilmikofenolat
• serious diseases of the bone marrow
• problemi s bubrezima
Pleural effusion, dyspnoea, cough
stomatitis, konstipacija, dispepsija, flatulencija, eruktacija
• The Package Leaflet
• začepljena crijeva
In contrast, there was an increase of approximately 20% in tacrolimus AUC when multiple doses of mycophenolate mofetil (1.5 g taken twice a day [BID], morning and evening) were administered to hepatic transplant patients taking tacrolimus.
Međutim, u bolesnika s presađenom jetrom koji su uzimali takrolimus, došlo je do povećanja AUC-a takrolimusa za otprilike 20 % pri uzimanju višestrukih doza mofetilmikofenolata (1,5 g dvaput dnevno, ujutro i uvečer) (vidjeti i dio 4.4).
Hepatitis, jaundice, hyperbilirubinaemia
Poremećaji jetre i žuči vrlo često često hepatitis, žutica, hiperbilirubinemija
Yellow iron oxide (E172)
Tijelo crveni željezov oksid (E172) žuti željezov oksid (E172) titanijev dioksid (E171) želatina
No data are available for cardiac transplant patients with severe hepatic parenchymal disease.
Nema podataka o primjeni u bolesnika s presađenim srcem i teškim oštećenjem jetrenog parenhima.
Trimethoprim/sulfamethoxazole No effect on the bioavailability of MPA was observed.
Nije opažen učinak na bioraspoloživost MPA-a.
The recommended dose in cardiac transplant patients is 1.5°g administered twice daily (3°g daily dose).
Preporučena doza za bolesnike s presađenim srcem iznosi 1,5 g dvaput dnevno (dnevna doza od 3 g).
Contact your nearest hospital Accident and Emergency department or a doctor for advice if you have swallowed more tablets than you have been told to take or if you think a child has swallowed any.
Ako popijete više tableta nego što Vam je propisano ili ako mislite da je Vaše dijete progutalo tabletu, za savjet se obratite na odjel hitne službe u najbližoj bolnici ili svom liječniku.
The recommended oral dose in hepatic transplant patients is 1.5°g administered twice daily (3°g daily dose).
Preporučena oralna doza za bolesnike s presađenom jetrom iznosi 1,5 g dvaput dnevno (dnevna doza od 3 g).
• Are you taking any medicines containing: o azathioprine or other immunosuppressive agents (which are sometimes given to patients after a transplant operation), o cholestyramine (used to treat patients with high blood cholesterol), o rifampicin (antibiotic), o antacids or proton pump inhibitors (used for acid problem in your stomach such as indigestion), o phosphate binders (used in patients with chronic kidney failure to reduce the absorption of phosphate), o antibiotics (used to treat bacterial infections), o isavuconazole (used to treat fungal infections), o telmisartan (used to treat high blood pressure) o or any other medicines (including those you can buy without a prescription) that your doctor does not know about?
• Uzimate li bilo koji lijek koji sadrži o azatioprin ili druge imunosupresivne lijekove (koji se ponekad daju bolesnicima nakon presađivanja), o kolestiramin (koristi se za liječenje bolesnika s visokim kolesterolom u krvi),
The recommended dose in renal transplant patients is 1 g administered twice daily (2 g daily dose).
Preporučena doza za bolesnike s presađenim bubregom iznosi 1 g dvaput dnevno (dnevna doza od 2 g).
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Dobroćudne, zloćudne i nespecificirane novotvorine
Alvogen ehf.
PRILOG III.
Gastrointestinal haemorrhage, peritonitis, ileus, colitis, gastric ulcer, duodenal ulcer, gastritis, oesophagitis, stomatitis, constipation, dyspepsia, flatulence, eructation
želučani ulkus, ulkus dvanaesnika, gastritis, ezofagitis,
Conversely, changes of MPA exposure should be expected when switching patients from CsA to one of the immunosuppressants which does not interfere with MPA´s enterohepatic cycle.
na neki od imunosupresiva koji ne interferiraju s enterohepatičnom cirkulacijom MPA, treba očekivati promjene u izloženosti MPA-u.
Capsule shell
Ovojnica kapsula
By interfering with enterohepatic circulation of the drug, bile acid sequestrants such as cholestyramine, reduce MPA AUC (see section 4.9).
poput kolestiramina, snizuju AUC MPA (vidjeti dio 4.9).
Croscarmellose sodium
Trimetoprim/sulfametoksazol
Hypromellose (HPMC 2910) Titanium dioxide (E171) Macrogol (PEG 400) Talc
Ovojnica tablete hipromeloza (HPMC 2910) titanijev dioksid (E171) makrogol (PEG 400) talk indigo carmine aluminium lake (E132) željezov oksid, crni (E172) željezov oksid, crveni (E172)
Paediatric population aged 2 to 18 years The recommended dose of mycophenolate mofetil is 600 mg/m2 administered orally twice daily (up to a maximum of 2 g daily).
Preporučena doza mofetilmikofenolata iznosi 600 mg/m2, primjenjena oralno dvaput dnevno (najviše
Agitation, confusional state, depression, anxiety, thinking abnormal, insomnia
Psihijatrijski poremećaji vrlo često često agitacija, konfuzno stanje, depresija, anksioznost,
The recommended dose of 1°g administered twice a day for renal transplant patients and 1.5°g twice a day for cardiac or hepatic transplant patients is appropriate for the elderly.
Za starije se osobe preporučuje doza od 1 g dvaput dnevno ako im je presađen bubreg te 1,5 g dvaput dnevno ako im je presađeno srce ili jetra.
System organ class Frequency Adverse drug reactions
Klasifikacija organskih sustava
Capsule content
Ovojnica kapsule
PRCA may resolve with dose reduction or cessation of Myfenax therapy.
MPA pa nije potrebno smanjiti dozu ni prekinuti primjenu Myfenaxa.
Myfenax should be administered with caution in patients with active serious digestive system disease.
Kod bolesnika s aktivnom ozbiljnom bolešću probavnog sustava Myfenax se mora primjenjivati s oprezom.
Arthralgia
Takrolimus
• fungal infection of the digestive tract
• gljivična infekcija probavnog sustava • infekcija mokraćnog sustava
Therefore, a change in the dose of Myfenax should not normally be necessary in the absence of clinical evidence of graft dysfunction.
Stoga, ako nema kliničkih dokaza disfunkcije presatka, promjena doze mofetilmikofenolata obično nije potrebna.
• The active substance is mycophenolate mofetil. Each tablet contains 500mg of mycophenolate mofetil.
• Djelatna tvar je 500 mg mofetilmikofenolata.
Myfenax 500mg film-coated tablets Mycophenolate mofetil
Myfenax 500mg filmom obložene tablete mofetilmikofenolat
How to store Myfenax
Moguće nuspojave Kako čuvati Myfenax
The highest dose tested in the animal carcinogenicity studies resulted in approximately 2-3 times the systemic exposure (AUC or Cmax) observed in renal transplant patients at the recommended clinical dose of 2 g/day and 1.3-2°times the systemic exposure (AUC or Cmax) observed in cardiac transplant patients at the recommended clinical dose of 3 g/day.
(AUC ili Cmax) od primijećene kod bolesnika s presađenim bubregom pri preporučenoj kliničkoj dozi od 2 g/dan te 1,3 - 2 puta većom sistemskom izloženošću(AUC ili Cmax) od primijećene kod bolesnika s presađenim srcem pri preporučenoj kliničkoj dozi od 3 g/dan.
• chest cold, sore throat, inflammation of the sinuses, stuffy and runny nose, sneezing
• upala bronha, upala grla, upala sinusa, začepljen nos i curenje iz nosa, kihanje • rak kože izrasline na koži koje nisu povezane sa rakom
The highest dose tested in the animal carcinogenicity studies resulted in approximately 2-3 times the systemic exposure (AUC or Cmax) observed in renal transplant patients at the recommended clinical dose of 2 g/day and 1.3-2 times the systemic exposure (AUC or Cmax) observed in cardiac transplant patients at the recommended clinical dose of 3 g/day.
(AUC ili Cmax) od primijećene kod bolesnika s presađenim bubregom pri preporučenoj kliničkoj dozi od 2 g/dan te 1,3 - 2 puta većom sistemskom izloženošću (AUC ili Cmax) od primijećene kod bolesnika s presađenim srcem pri preporučenoj kliničkoj dozi od 3 g/dan.
Medicinal products that affect glucuronidation (e.g. isavuconazole, telmisartan) Concomitant administration of drugs inhibiting glucuronidation of MPA may increase MPA exposure.
Istodobna primjena lijekova koji inhibiraju glukuronidaciju MPA-a može povećati izloženost MPA-u.
• Congenital choroid plexus cyst;
• prirođene ciste na koroidnom pleksusu
Very common Sepsis, gastrointestinal candidiasis, urinary tract infection, herpes simplex, herpes zoster
citomegalovirusna (CMV) viremija/sindrom i herpes simpleks.
• Tracheo-Oesophageal malformations (e.g. oesophageal atresia);
česte infekcije) (agranulocitoza)
System organ class Frequency Adverse drug reactions hypercholesterolaemia, hyperlipidaemia, hypophosphataemia, hyperuricaemia, gout, anorexia Psychiatric disorders Very commonCommon
Poremećaji krvi i limfnog sustava vrlo često leukopenija, trombocitopenija, anemija često pancitopenija, leukocitoza
Lymphoproliferative disease or lymphoma developed in 0.6% of patients receiving mycophenolate mofetil (2°g or 3°g daily) in combination with other immunosuppressants in controlled clinical trials of renal (2°g data), cardiac and hepatic transplant patients followed for at least 1°year.
bolesnika koji su primali mofetilmikofenolat (2 g ili 3 g dnevno) u kombinaciji s drugim imunosupresivima, došlo je do razvoja limfoproliferativne bolesti ili limfoma.
Skin hypertrophy, rash, acne, alopecia
Poremećaji kože i potkožnog tkiva vrlo često često hipertrofija kože, osip, akne, alopecija
Excipient
OBLIK
The mean bioavailability of oral mycophenolate mofetil, based on MPA AUC, is 94% relative to intravenous mycophenolate mofetil. Food had no effect on the extent of absorption (MPA AUC) of mycophenolate mofetil when administered at doses of 1.5°g BID to renal transplant patients.
Hrana nema utjecaj na veličinu apsorpcije (AUC-a MPA) mofetilmikofenolata kad se kod bolesnika s presađenim bubregom primjenjuje u dozama od 1,5 g dvaput dnevno.
Name and address of the manufacturers responsible for batch release
Naziv i adresa proizvođača odgovornih za puštanje serije lijeka u promet Teva Pharmaceutical Works Private Limited Company Pallagi út 13.
Skin and subcutaneous tissue disorders
• herpes i herpes zoster
Kidney Transplant
Presađivanje bubrega
• Before you start taking Myfenax
To uključuje: • razdoblje prije početka uzimanja lijeka Myfenax
Mycophenolic acid (MPA) is the active metabolite of mycophenolate mofetil. Renal transplant rejection does not lead to changes in MPA pharmacokinetics; dosage reduction or interruption of Myfenax is not required.
Myfenax je lijek za suprimiranje imunološke aktivnosti Djelatna tvar u ovom lijeku zove se mofetilmikofenolat.
You must not donate blood during treatment with Myfenax and for at least 6 weeks after stopping treatment.
Tijekom liječenja lijekom Myfenax i najmanje 6 tjedana nakon prestanka liječenja ne smijete darivati krv.
• inflammation of the digestive tract
• upala probavnog sustava
Patients receiving immunosuppressive regimens involving combinations of medicinal products, including mycophenolate mofetil, are at increased risk of developing lymphomas and other malignancies, particularly of the skin (see section 4.4).
Bolesnici koji primaju imunosupresivnu terapiju koja obuhvaća kombinaciju lijekova, uz ostalo i mofetilmikofenolat, izloženi su povećanom riziku od nastajanja limfoma i drugih zloćudnih bolesti,
Cyprus domperidone Costi
Cyprus domperidon Costi
Diagonal, 67-69 Barcelona
Diagonal, 67-69
Str. Fabricii nr. 124, Cluj Napoca, Romania
Fabricii nr. 124, Cluj Napoca, Romania
Domperidone COSTI
Domperidon COSTI
List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the Member States
Popis naziva, farmaceutskih oblika, jačina lijekova, puteva primjene, nositelja odobrenja u državama članicama
Via Nocera Umbra 75, 00181 Roma
Via Nocera Umbra 75, 00181 Roma Italy
Domperidone NEOPERIDYS
Domperidon NEOPERIDYS
10 mg capsule, hard
10 mg kapsula, tvrda
United Kingdom Athlone Pharmaceuticals Limited, Ballymurray, Roscommon, Co.
Athlone Pharmaceuticals Limited, Ballymurray, Roscommon, Co.
Johnson & Johnson D.O.O Smartinska cesta 53 1000 Ljubljana Slovenia domperidone Motilium
Johnson & Johnson D.O.O Smartinska cesta 53 1000 Ljubljana Slovenia domperidon Motilium
LABORATORIOS DR. ESTEVE, S.A. Avda.
Španjolska LABORATORIOS DR. ESTEVE, S.A. Avda.
4230 Skaelskoer Denmark domperidone Domperidon "Alternova"
4230 Skaelskoer Denmark domperidon Domperidon "Alternova"
150 00 Praha 5 - Smíchov Czech Republic domperidone Motilium
150 00 Praha 5 - Smíchov Czech Republic domperidon Motilium
Belgium domperidone Motilium Domperidone Base
Belgium domperidon Motilium Domperidone Base
Šmarješka cesta 6 8501 Novo mesto Slovenia domperidone Tametil 10 mg filmsko obložene tablete
Šmarješka cesta 6 8501 Novo mesto Slovenia domperidon Tametil 10 mg filmsko obložene tablete
Belgium domperidone Motilium-10 supp.
Belgium domperidon Motilium-10 supp.
mg/100 ml syrup
mg/100 ml sirup
Wise Pharmaceuticals Ltd.
Nizozemska Wise Pharmaceuticals Ltd.
Lagoas Park, Edifício 5 A, Piso 2 2740-245 Porto Salvo Portugal domperidone Domperidona Ratiopharm
Lagoas Park, Edifício 5 A, Piso 2 2740-245 Porto Salvo Portugal domperidon Domperidona Ratiopharm
Athens, Greece domperidone OROPERIDYS
Athens, Greece domperidon OROPERIDYS
Samenwerkende Apothekers Nederland B.V.
Nizozemska Samenwerkende Apothekers Nederland B.V.
10 mg/10 ml suspension
10 mg/10 ml suspenzija
Limassol CY-3505 Cyprus domperidone Costi 10mg Film coated tablets
Limassol CY-3505 Cyprus domperidon Costi 10mg Film coated tablets
Greece domperidone CILROTON
Greece domperidon CILROTON
3460 Birkeroed Denmark domperidone Motilium
3460 Birkeroed Denmark domperidon Motilium
H-2045 Törökbálint Hungary domperidone Motilium 10 mg filmtabletta
H-2045 Törökbálint Hungary domperidon Motilium 10 mg filmtabletta
Avenida do Forte, 3 - Edificio Suécia III, Piso 1
ToLife - Produtos Farmacêuticos, S.A. Avenida do Forte, 3 - Edificio Suécia III, Piso 1
MEDOCHEMIE LTD 1-10 Constantinoupoleos Str, P.O.Box 51409, Lemesos Cyprus domperidone COSTI TABLETS 10MG
MEDOCHEMIE LTD 1-10 Constantinoupoleos Str, P.O.Box 51409, Lemesos Cyprus domperidon COSTI TABLETS 10MG 10 mg tableta
UAB „Johnson & Johnson“ Geležinio Vilko g. 18A LT-08104 Vilnius Lithuania domperidone Motilium 10 mg filmcoated tablets
UAB „Johnson & Johnson“ Geležinio Vilko g. 18A LT-08104 Vilnius Lithuania domperidon Motilium 10 mg filmcoated tablets
Luxembourg Johnson & Johnson Consumer N.V. Antwerpseweg 15-17
Luksemburg Johnson & Johnson Consumer N.V. Antwerpseweg 15-17
United Kingdom Co-operative Pharmacy National Distribution Centre Limited, Enterprose Way, Meir Park, Stokeon-Trent, Staffordshire ST3 7UN United Kingdom domperidone maleate
Co-operative Pharmacy National Distribution Centre Limited, Enterprose Way, Meir Park, Stokeon-Trent, Staffordshire ST3 7UN United Kingdom domperidon maleat
Domperidone Domperidone instant EG
Domperidon Domperidone instant EG
Domperidone PYNINAT
Domperidon PYNINAT
Labesfal Genéricos, S.A Avenida Dr. Afonso Costa, 1370 3465-051 Campo de Besteiros Portugal domperidone Domperidona Labesfal
Labesfal Genéricos, S.A Avenida Dr. Afonso Costa, 1370 3465-051 Campo de Besteiros Portugal domperidon Domperidona Labesfal 10 mg tableta
Domperidone DALIA
Domperidon DALIA
United Kingdom Milpharm Limited, Ares Block, Odyssey Business Park, West End Road, Ruislip, HA4 6QD, United Kingdom domperidone maleate
Milpharm Limited, Ares Block, Odyssey Business Park, West End Road, Ruislip, HA4 6QD, United Kingdom domperidon maleat
PENSA PHARMA, S.A.U.
Španjolska PENSA PHARMA, S.A.U.
Domperidone DOMPERIDONE GERMED
Domperidon DOMPERIDONE GERMED
Domperidone DOMPERIDONE TEVA
Domperidon teva
Belgium Kela Pharma nv Industriepark 68
Nizozemska KELA Pharma nv Industriepark West 68
Actavis A/S Sucursal Rua Virgílio Correia, 11 - A 1600-219 Lisboa Portugal domperidone Domperidona Actavis
Actavis A/S Sucursal Rua Virgílio Correia, 11 - A 1600-219 Lisboa Portugal domperidon Domperidona Actavis 10 mg tableta
1 mg/ml suspension
1 mg/ml suspenzija
Domperidone Domperidona Gamir 10 mg cápsulas duras
Domperidon Domperidona Gamir 10 mg cápsulas duras
Domperidone RAXAR
Domperidon RAXAR
United Kingdom McNeil Products Limited, Johnson & Johnson Ltd, Foundation Park, Roxborough Way, Maidenhead, Berkshire SL6 3UG,
McNeil Products Limited, Johnson & Johnson Ltd, Foundation Park, Roxborough Way, Maidenhead, Berkshire SL6 3UG, United Kingdom
Parque Expo, Edifício Atlantis, Avenida D. João II, Lote 1.06.2.2 C - 7.3 e 7.4
João II, Lote 1.06.2.2 C7.3 e 7.4
United Kingdom Medreich plc, Warwick House, Plane Tree Crescent, Feltham TW13 7HF United Kingdom domperidone maleate
Warwick House, Plane Tree Crescent, Feltham TW13 7HF United Kingdom domperidon maleat
Pº de Las Doce Estrellas, 5-7 28042 Madrid
Španjolska Janssen-Cilag, S.A. Pº de Las Doce Estrellas, 5-7 28042 Madrid
Belgium Johnson & Johnson Consumer N.V. Antwerpseweg 15-17
Johnson & Johnson Consumer N.V. Antwerpseweg 15-17
Belgium domperidone Motilium-1mg/ml
Belgium domperidon Motilium-1mg/ml
2730-055 Barcarena Portugal domperidone Motilium Rapid
2730-055 Barcarena Portugal domperidon Motilium Rapid
20 mg/ 19 mg tablet
20 mg/ 19 mg tableta
Baldacci - Portugal, S.A. Rua Cândido de Figueiredo, 84-B 1549-005 Lisboa Portugal domperidone Domperidona Baldacci
Baldacci - Portugal, S.A. Rua Cândido de Figueiredo, 84-B 1549-005 Lisboa Portugal domperidon Domperidona Baldacci 10 mg filmom obložena tableta
Domperidone GERDI
Domperidon GERDI
ZYDUS FRANCE 25, rue des Peupliers ZAC Les Hautes Pâtures - Parc d'Activités des Peupliers 92000 Nanterre France domperidone DOMPERIDONE ZYDUS 10 mg, comprimé pelliculé
ZYDUS FRANCE 25, rue des Peupliers ZAC Les Hautes Pâtures - Parc d'Activités des Peupliers 92000 Nanterre France domperidon DOMPERIDONE ZYDUS 10 mg, comprimé pelliculé
Romania
Rumunija
Domperidone DOMPERIDONE MYLAN GENERICS
Domperidon DOMPERIDONE MYLAN GENERICS
20 mg / 15 mg tablet
20 mg / 15 mg tableta
Austria domperidone Motilium 1 mg/mlSuspension zum
Austria domperidon Motilium 1 mg/mlSuspension zum
Domperidone Motilium Tropfen 10 mg oral drops, suspension
Domperidon Motilium Tropfen 10 mg oralne kapi, suspenzija
Accord Healthcare Ltd Sage House, 319 Pinner Road HA1 4 HF North Harrow, Middlesex United Kingdom
Nizozemska Accord Healthcare Ltd Sage House, 319 Pinner Road HA1 4 HF North Harrow, Middlesex United Kingdom
Domperidone Domstal
Domperidon Domstal
Domperidone Motilium suspensie voor oraal gebruik 1 mg/ml
Domperidon Motilium suspensie voor oraal gebruik 1 mg/ml
Domperidone DOMPERIDONE SANDOZ
Domperidon DOMPERIDONE SANDOZ
2794-093 Carnaxide Portugal domperidone Domperidona ToLife 10 mg tablet
2794-093 Carnaxide Portugal domperidon Domperidona ToLife 10 mg tableta
Domperidone Motilium instant
Domperidon Motilium instant
Domperidone PERIDON
Domperidon PERIDON
SUBSTIPHARM 8, rue Bellini 75116 Paris France domperidone DOMPERIDONE GERDA 10 mg, comprimé pelliculé
SUBSTIPHARM 8, rue Bellini 75116 Paris France domperidon DOMPERIDONE GERDA 10 mg, comprimé pelliculé
2730-055 Barcarena Portugal domperidone Motilium
2730-055 Barcarena Portugal domperidon Motilium
Domperidone DOMPERIDONE DOC GENERICI
Domperidon DOMPERIDONE DOC GENERICI
ACTAVIS FRANCE La Boursidière Centre d'Affaires 92357 Le Plessis Robinson France domperidone DOMPERIDONE ACTAVIS 10 mg, comprimé pelliculé
ACTAVIS FRANCE La Boursidière Centre d'Affaires 92357 Le Plessis Robinson France domperidon DOMPERIDONE ACTAVIS 10 mg, comprimé pelliculé
Cinnarizine / Domperidone (maleate)
Cinarizin / Domperidon (maleat)
Rua Alto do Montijo, 13 - 1º DtoEdifício Monsanto 2790-012 Portela de Carnaxide Portugal domperidone Domperidona Germed
Rua Alto do Montijo, 13 - 1º DtoEdifício Monsanto 2790-012 Portela de Carnaxide Portugal domperidon Domperidona Germed 10 mg filmom obložena tableta
United Kingdom Winthrop Pharmaceuticals UK Limited, One Onslow Street, Guildford, Surrey GU1 4YS, United Kingdom domperidone Domperidone 1mg/ml Oral
Winthrop Pharmaceuticals UK Limited, One Onslow Street, Guildford, Surrey GU1 4YS, United Kingdom domperidon Domperidone 1mg/ml Oral Suspension
CRISTERS 22 quai Gallieni 92150 Suresnes France domperidone DOMPERIDONE CRISTERS 10 mg, comprimé orodispersible
CRISTERS 22 quai Gallieni 92150 Suresnes France domperidon DOMPERIDONE CRISTERS 10 mg, comprimé orodispersible
Domperidone Oroperidys
Domperidon Oroperidys
United Kingdom Winthrop Pharmaceuticals UK Limited, One Onslow Street, Guildford, Surrey GU1 4YS United Kingdom domperidone maleate
Winthrop Pharmaceuticals UK Limited, One Onslow Street, Guildford, Surrey GU1 4YS United Kingdom domperidon maleat
Domperidone RIGES
Domperidon RIGES
Domperidone Tabletten bij maagklachten en misselijkheid domperidon 10 mg, tabletten
Domperidon Tabletten bij maagklachten en misselijkheid domperidon 10 mg, tabletten
B-2340, Beerse Belgium domperidone motilium 10mg film coated tablets
B-2340, Beerse Belgium domperidon motilium 10mg film coated tablets
5 mg/5 ml oral solution
5 mg/5 ml oralna otopina
B-2340, Beerse Belgium domperidone motilium 1mg/ml oral suspension
B-2340, Beerse Belgium domperidon motilium 1mg/ml oral suspension
Marel B.V.
Nizozemska Marel B.V.
Karla Engliše 3201/6
Češka Republika Janssen-Cilag s.r.o. Karla Engliše 3201/6
domperidone DOMPERIDONE ALTER 10 mg, comprimé pelliculé
domperidon DOMPERIDONE ALTER 10 mg, comprimé pelliculé
Generis Farmacêutica, S.A. Rua João de Deus, 19 2700-487 Amadora Portugal domperidone Domperidona Generis
Generis Farmacêutica, S.A. Rua João de Deus, 19 2700-487 Amadora Portugal domperidon Domperidona Generis 10 mg filmom obložena tableta
Leidapharm B.V.
Nizozemska Leidapharm B.V.
United Kingdom domperidone maleate
United Kingdom domperidon maleat
Austria domperidone Motilium 10 mgFilmtabletten
Austria domperidon Motilium 10 mgFilmtabletten